RDY Dr. Reddy's Laboratories Limited

NYSE
$12.18

Dr. Reddy's Laboratories Limited (RDY) is expected to report earnings on October 28, 2026, during market hours. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.5% since its last earnings release on July 22, 2026.

Dr. Reddy's Laboratories Limited Missed Consensus Estimates
Wednesday, July 22, 2026 · 12:00 AM ET
Earnings Date
2nd Quarter, Sep 2026
Oct 28
Wednesday · Market Hours
Earnings Whisper
-
vs $0.16
Rev est $967.93M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $11.99

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dr. Reddy's Laboratories Limited

Dr Reddy Laboratories Ltd together with its subsidiaries is engaged in manufacturing of pharmaceutical products. It operates through three segments; Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products.

Sector

Healthcare

Industry

Drugs - Generic